Human kallikrein 4: enzymatic activity, inhibition, and degradation of extracellular matrix proteins

References

Abbott, A. (2004). Biologists take degrading route to tackle cancer. Nature429, 794.10.1038/429794aSearch in Google Scholar

Anisowicz, A., Sotiropoulou, G., Stenman, G., Mok, S.C., and Sager, R. (1996). A novel protease homolog differentially expressed in breast and ovarian cancer. Mol. Med.2, 624–636.10.1007/BF03401646Search in Google Scholar

Borgono, C.A., Michael, I.P., and Diamandis, E.P. (2004). Human tissue kallikreins: physiologic roles and applications in cancer. Mol. Cancer Res.2, 257–280.10.1158/1541-7786.257.2.5Search in Google Scholar

Brattsand, M. and Egelrud, T. (1999). Purification, molecular cloning, and expression of a human stratum corneum trypsin-like serine protease with possible function in desquamation. J. Biol. Chem.274, 30033–30040.10.1074/jbc.274.42.30033Search in Google Scholar

Caine, G.J., Lip, G.Y., Stonelake, P.S., Ryan, P., and Blann, A.D. (2004). Platelet activation, coagulation and angiogenesis in breast and prostate carcinoma. Thromb. Haemost.92, 185–190.10.1160/TH03-11-0679Search in Google Scholar

Caughey, G.H. (2002). New developments in the genetics and activation of mast cell proteases. Mol. Immunol.38, 1353–1357.10.1016/S0161-5890(02)00087-1Search in Google Scholar

Christensen, S., Valnickova, Z., Thogersen, I.B., Olsen, E.H., and Enghild, J.J. (1997). Assignment of a single disulphide bridge in human alpha2-antiplasmin: implications for the structural and functional properties. Biochem. J.323, 847–852.10.1042/bj3230847Search in Google Scholar PubMed PubMed Central

Clements, J., Hooper, J., Dong, Y., and Harvey, T. (2001). The expanded human kallikrein (KLK) gene family: genomic organisation, tissue-specific expression and potential functions. Biol. Chem.382, 5–14.10.1515/BC.2001.002Search in Google Scholar PubMed

Clements, J., Willemsen, N.M., Myers, S.A., and Dong, Y. (2004). The tissue kallikrein family of serine proteases: functional roles in human disease and potential as clinical biomarkers. Crit. Rev. Clin. Lab. Sci.41, 265–312.10.1080/10408360490471931Search in Google Scholar PubMed

Day, C.H., Fanger, G.R., Retter, M.W., Hylander, B.L., Penetrante, R.B., Houghton, R.L., et al. (2002). Characterization of KLK4 expression and detection of KLK4-specific antibody in prostate cancer patient sera. Oncogene21, 7114–7120.10.1038/sj.onc.1205786Search in Google Scholar PubMed

Declerck, P.J., De Mol, M., Vaughan, D.E., and Collen, D. (1992). Identification of a conformationally distinct form of plasminogen activator inhibitor-1, acting as a noninhibitory substrate for tissue-type plasminogen activator. J. Biol. Chem.267, 11693–11696.10.1016/S0021-9258(19)49751-2Search in Google Scholar

Dong, Y., Kaushal, A., Bui, L., Chu, S., Fuller, P.J., Nicklin, J., et al. (2001). Human kallikrein 4 (KLK4) is highly expressed in serous ovarian carcinomas. Clin. Cancer Res.7, 2363–2371.Search in Google Scholar

Doolittle, R.F. and Feng, D.F. (1987). Reconstructing the evolution of vertebrate blood coagulation from a consideration of the amino acid sequences of clotting proteins. Cold Spring Harbor Symp. Quant. Biol.52, 869–874.10.1101/SQB.1987.052.01.095Search in Google Scholar

Edman, P. (1970). Sequence determination. Mol. Biol. Biochem. Biophys.8, 211–255.10.1007/978-3-662-12834-3_8Search in Google Scholar

Ekholm, E. and Egelrud, T. (1999). Stratum corneum chymotryptic enzyme in psoriasis. Arch. Dermatol. Res.291, 195–200.10.1007/s004030050393Search in Google Scholar

Farries, T.C. and Atkinson, J.P. (1991). Evolution of the complement system. Immunol. Today12, 295–300.10.1016/0167-5699(91)90002-BSearch in Google Scholar

Gan, L., Lee, I., Smith, R., Argonza-Barrett, R., Lei, H., McCuaig, J., et al. (2000). Sequencing and expression analysis of the serine protease gene cluster located in chromosome 19q13 region. Gene257, 119–130.10.1016/S0378-1119(00)00382-6Search in Google Scholar

Hansson, L., Stromqvist, M., Backman, A., Wallbrandt, P., Carlstein, A., and Egelrud, T. (1994). Cloning, expression, and characterization of stratum corneum chymotryptic enzyme. A skin-specific human serine proteinase. J. Biol. Chem.269, 19420–19426.Search in Google Scholar

Hart, P.S., Wright, J.T., Savage, M., Kang, G., Bensen, J.T., Gorry, M.C., et al. (2003). Exclusion of candidate genes in two families with autosomal dominant hypocalcified amelogenesis imperfecta. Eur. J. Oral Sci.111, 326–331.10.1034/j.1600-0722.2003.00046.xSearch in Google Scholar

Hart, P.S., Hart, T.C., Michalec, M.D., Ryu, O.H., Simmons, D., Hong, S., et al. (2004). Mutation in kallikrein 4 causes autosomal recessive hypomaturation amelogenesis imperfecta. J. Med. Genet.41, 545–549.10.1136/jmg.2003.017657Search in Google Scholar

Hu, J.C., Zhang, C., Sun, X., Yang, Y., Cao, X., Ryu, O., et al. (2000). Characterization of the mouse and human PRSS17 genes, their relationship to other serine proteases, and the expression of PRSS17 in developing mouse incisors. Gene251, 1–8.10.1016/S0378-1119(00)00203-1Search in Google Scholar

Hu, J.C., Sun, X., Zhang, C., Liu, S., Bartlett, J.D., and Simmer, J.P. (2002). Enamelysin and kallikrein-4 mRNA expression in developing mouse molars. Eur. J. Oral Sci.110, 307–315.10.1034/j.1600-0722.2002.21301.xSearch in Google Scholar PubMed

Huntington, J.A., Read, R.J., and Carrell, R.W. (2000). Structure of a serpin-protease complex shows inhibition by deformation. Nature407, 923–926.10.1038/35038119Search in Google Scholar

Kanazawa, H., Kurihara, N., Hirata, K., Fujimoto, S., and Takeda, T. (1992). The role of free radicals and neutrophil elastase in development of pulmonary emphysema. Intern. Med.31, 857–860.10.2169/internalmedicine.31.857Search in Google Scholar

Kalsheker, N. (1989). α1-Antitrypsin: structure, function and molecular biology of the gene. Biosci. Rep.9, 129–138.10.1007/BF01115992Search in Google Scholar

Kapadia, C., Yousef, G.M., Mellati, A.A., Magklara, A., Wasney, G.A., and Diamandis, E.P. (2004). Complex formation between human kallikrein 13 and serum protease inhibitors. Clin. Chim. Acta339, 157–167.10.1016/j.cccn.2003.10.009Search in Google Scholar

Khan, A.R. and James, M.N. (1998). Molecular mechanisms for the conversion of zymogens to active proteolytic enzymes. Protein Sci.7, 815–836.10.1002/pro.5560070401Search in Google Scholar

Komatsu, N., Takata, M., Otsuki, N., Toyama, T., Ohka, R., Takehara, K., et al. (2003). Expression and localization of tissue kallikrein mRNAs in human epidermis and appendages. J. Invest. Dermatol.121, 542–549.10.1046/j.1523-1747.2003.12363.xSearch in Google Scholar

Korkmaz, K.S., Korkmaz, C.G., Pretlow, T.G., amd Saatcioglu. F. (2001). Distinctly different gene structure of KLK4/KLK-L1/prostase/ARM1 compared with other members of the kallikrein family: intracellular localization, alternative cDNA forms, and regulation by multiple hormones. DNA Cell Biol.20, 435–445.10.1089/104454901750361497Search in Google Scholar

Kraut, J., Wright, H.T., Kellerman, M., and Freer, S.T. (1967). Pi-, delta-, and gamma-chymotrypsin: thee-dimensional electron-density and difference maps at 5 Å resolution, and comparison with chymotrypsinogen. Proc. Natl. Acad. Sci. USA58, 304–311.10.1073/pnas.58.1.304Search in Google Scholar

Lilja, H., Chistensson, A., Dahlen, U., Matikainen, M.T., Nilsson O., Pettersson, K., et al. (1991). Prostate-specific antigen in serum occurs predominantly in complex with α₁-antichymotrypsin. Clin. Chem.37, 1618–1625.10.1093/clinchem/37.9.1618Search in Google Scholar

Lin, F.K., Lin, C.H., Chou, C.C., Chen, K., Lu, H.S., Bacheller, W., et al. (1993). Molecular cloning and sequence analysis of the monkey and human tissue kallikrein genes. Biochim. Biophys. Acta1173, 325–328.10.1016/0167-4781(93)90131-VSearch in Google Scholar

Lipinska, I., Lipinski, B., Gurewich, V., and Hoffmann, K.D. (1976). Fibrinogen heterogeneity in cancer, in occlusive vascular disease, and after surgical procedures. Am. J. Clin. Pathol.66, 958–966.10.1093/ajcp/66.6.958Search in Google Scholar

Little, S.P., Dixon, E.P., Norris, F., Buckley, W., Becker, G.W., Johnson, M., et al. (1997). Zyme, a novel and potentially amyloidogenic enzyme cDNA isolated from Alzheimer's disease brain. J. Biol. Chem.272, 25135–25142.10.1074/jbc.272.40.25135Search in Google Scholar

Liu, X.L., Wazer, D.E., Watanabe, K., and Band, V. (1996). Identification of a novel serine protease-like gene, the expression of which is down-regulated during breast cancer progression. Cancer Res.56, 3371–3379.Search in Google Scholar

Longas, M.O. and Finlay, T.H. (1980). The covalent nature of the human antithrombin III-thrombin bond. Biochem. J.189, 481–489.10.1042/bj1890481Search in Google Scholar

Lovgren, J., Airas, K., and Lilja, H. (1999). Enzymatic action of human glandular kallikrein 2 (hK2). Substrate specificity and regulation by Zn²⁺ and extracellular protease inhibitors. Eur. J. Biochem.262, 781–789.Search in Google Scholar

Luo, L., Herbrick, J.A., Scherer, S.W., Beatty, B., Squire, J., and Diamandis, E.P. (1998). Structural characterization and mapping of the normal epithelial cell-specific 1 gene. Biochem. Biophys. Res. Commun.247, 580–586.10.1006/bbrc.1998.8793Search in Google Scholar

Magklara, A., Mellati, A.A., Wasney, G.A., Little, S.P., Sotiropoulou, G., Becker, G.W., et al. (2003). Characterization of the enzymatic activity of human kallikrein 6: autoactivation, substrate specificity, and regulation by inhibitors. Biochem. Biophys. Res. Commun.307, 948–955.10.1016/S0006-291X(03)01271-3Search in Google Scholar

Matsumura, M., Bhatt, A.S., Andress, D., Clegg, N., Takayama, T.K., Craik, C.S., et al. (2005). Substrates of the prostate-specific serine protease prostase/KLK4 defined by positional-scanning peptide libraries. Prostate62, 1–13.10.1002/pros.20101Search in Google Scholar

Morii, M. and Travis, J. (1983). Amino acid sequence at the reactive site of human alpha 1-antichymotrypsin. J. Biol. Chem.258, 12749–12752.10.1016/S0021-9258(17)44026-9Search in Google Scholar

Nagano, T., Oida, S., Ando, H., Gomi, K., Arai, T., and Fukae, M. (2003). Relative levels of mRNA encoding enamel proteins in enamel organ epithelia and odontoblasts. J. Dent. Res.82, 982–986.10.1177/154405910308201209Search in Google Scholar

Nelson, P.S., Gan, L., Ferguson, C., Moss, P., Gelinas, R., Hood, L., et al. (1999). Molecular cloning and characterization of prostase, an androgen-regulated serine protease with prostate-restricted expression. Proc. Natl. Acad. Sci. USA96, 3114–3119.10.1073/pnas.96.6.3114Search in Google Scholar

Neurath, H. (1989). Proteolytic processing and physiological regulation. Trends Biochem. Sci.14, 268–271.10.1016/0968-0004(89)90061-3Search in Google Scholar

Obiezu, C.V. and Diamandis, E.P. (2005). Human tissue kallikrein gene family: applications in cancer. Cancer Lett.224, 1–22.10.1016/j.canlet.2004.09.024Search in Google Scholar PubMed

Obiezu, C.V., Scorilas, A., Katsaros, D., Massobrio, M., Yousef, G.M., Fracchioli, S., et al. (2001). Higher human kallikrein gene 4 (klk4) expression indicates poor prognosis of ovarian cancer patients. Clin. Cancer Res.7, 2380–2386.Search in Google Scholar

Obiezu, C.V., Soosaipillai, A., Jung, K., Stephan, C., Scorilas, A., Howarth, D.H., et al. (2002). Detection of human kallikrein 4 in healthy and cancerous prostatic tissues by immunofluorometry and immunohistochemistry. Clin. Chem.48, 1232–1240.10.1093/clinchem/48.8.1232Search in Google Scholar

Paternoster, D., Maggino, T., Valente, S., Paternoster, A., Pengo, V., and Marchesoni, D. (1981). Fibrinogen degradation products (F.D.P.) in ascitic fluid of patients affected by ovarian cancer. Clin. Exp. Obstet. Gynecol.8, 64–65.Search in Google Scholar

Pereira, M., Rybarczyk, B.J., Odrljin, T.M., Hocking, D.C., Sottile, J., and Simpson-Haidaris, P.J. (2002). The incorporation of fibrinogen into extracellular matrix is dependent on active assembly of a fibronectin matrix. J. Cell Sci.115, 609–617.10.1242/jcs.115.3.609Search in Google Scholar PubMed

Potempa, J., Shieh, B.H., and Travis, J. (1988). Alpha-2-antiplasmin: a serpin with two separate but overlapping reactive sites. Science241, 699–700.10.1126/science.2456616Search in Google Scholar PubMed

Puente, X.S., Sanchez, L.M., Overall, C.M., and Lopez-Otin, C. (2003). Human and mouse proteases: a comparative genomic approach. Nat. Rev. Genet.4, 544–458.10.1038/nrg1111Search in Google Scholar PubMed

Ratnoff, O.D. (1972). The molecular basis of hereditary clotting disorders. Prog. Hemost. Thromb.1, 39–74.Search in Google Scholar

Rawlings, N.D. and Barrett, A.J. (1993). Evolutionary families of peptidases. Biochem. J.290, 205–218.10.1042/bj2900205Search in Google Scholar PubMed PubMed Central

Rittenhouse, H.G., Finlay, J.A., Mikolajczyk, S.D., and Partin, A.W. (1998). Human kallikrein 2 (hK2) and prostate-specific antigen (PSA): two closely related, but distinct, kallikreins in the prostate. Crit. Rev. Clin. Lab. Sci.35, 275–368.10.1080/10408369891234219Search in Google Scholar PubMed

Ryu, O., Hu, J.C., Yamakoshi, Y., Villemain, J.L., Cao, X., Zhang, C., et al. (2002). Porcine kallikrein-4 activation, glycosylation, activity, and expression in prokaryotic and eukaryotic hosts. Eur. J. Oral Sci.110, 358–365.10.1034/j.1600-0722.2002.21349.xSearch in Google Scholar PubMed

Sambrook, J., Fritsch, E.F., and Maniatis, T. (1989). Molecular Cloning: A Laboratory Manual, 2nd ed. (Cold Spring Harbor, NY, USA: Cold Spring Harbor Laboratory Press).Search in Google Scholar

Schwartz, L.B. (1992). Cellular inflammation in asthma: neutral proteases of mast cells. Am. Rev. Respir. Dis.145, S18–21.10.1164/ajrccm/145.2_Pt_2.S18Search in Google Scholar PubMed

Sheng, S. (2001). The urokinase-type plasminogen activator system in prostate cancer metastasis. Cancer Metastasis Rev.20, 287–296.10.1023/A:1015539612576Search in Google Scholar

Sim, R.B. and Laich, A. (2000). Serine proteases of the complement system. Biochem. Soc. Trans.28, 545–550.10.1042/bst0280545Search in Google Scholar

Stephenson, S.A., Verity, K., Ashworth, L.K., and Clements, J.A. (1999). Localization of a new prostate-specific antigen-related serine protease gene, KLK4, is evidence for an expanded human kallikrein gene family cluster on chromosome 19q13.3-13.4. J. Biol. Chem.274, 23210–23214.10.1074/jbc.274.33.23210Search in Google Scholar

Sottrup-Jensen, L. (1989). Alpha-macroglobulins: structure, shape, and mechanism of proteinase complex formation. J. Biol. Chem.264, 11539–11542.10.1016/S0021-9258(18)80094-1Search in Google Scholar

Sottrup-Jensen, L., Stepanik, T.M., Kristensen, T., Wierzbicki, D.M., Jones, C.M., Lonblad, P.B., et al. (1984). Primary structure of human α₂-macroglobulin. V. The complete structure. J. Biol. Chem.259, 8318–8327.Search in Google Scholar

Takayama, T.K., Fujikawa, K., and Davie, E.W. (1997). Characterization of the precursor of prostate-specific antigen. Activation by trypsin and by human glandular kallikrein. J. Biol. Chem.272, 21582–21588.10.1074/jbc.272.34.21582Search in Google Scholar

Takayama, T.K., McMullen, B.A., Nelson, P.S., Matsumura, M., and Fujikawa, K. (2001). Characterization of hK4 (prostase), a prostate-specific serine protease: activation of the precursor of prostate specific antigen (pro-PSA) and single-chain urokinase-type plasminogen activator and degradation of prostatic acid phosphatase. Biochemistry40, 15341–15348.10.1021/bi015775eSearch in Google Scholar

van Zonneveld, A.J., Veerman, H., MacDonald, M.E., van Mourik, J.A., and Pannekoek, H. (1986). Structure and function of human tissue-type plasminogen activator (t-PA). J. Cell Biochem.32, 169–178.10.1002/jcb.240320302Search in Google Scholar

Wang, D., Bode, W., and Huber, R. (1985). Bovine chymotrypsinogen: X-ray crystal structure analysis and refinement of a new crystal form at 1.8 Å resolution. J. Mol. Biol.185, 595–624.Search in Google Scholar

Wojtukiewicz, M.Z., Zacharski, L.R., Memoli, V.A., Kisiel, W., Kudryk, B.J., Moritz, T.E., et al. (1991). Fibrin formation on vessel walls in hyperplastic and malignant prostate tissue. Cancer67, 1377–1383.10.1002/1097-0142(19910301)67:5<1377::AID-CNCR2820670517>3.0.CO;2-2Search in Google Scholar

Wright, H.T. (1973). Activation of chymotrypsinogen-A. An hypothesis based upon comparison of the crystal structures of chymotrypsinogen-A and α-chymotrypsin. J. Mol. Biol.79, 13–23.10.1016/0022-2836(73)90266-0Search in Google Scholar

Xi, Z., Klokk, T.I., Korkmaz, K., Kurys, P., Elbi, C., Risberg, B., et al. (2004). Kallikrein 4 is a predominantly nuclear protein and is overexpressed in prostate cancer. Cancer Res.64, 2365–2370.10.1158/0008-5472.CAN-03-2025Search in Google Scholar

Yamashiro, K., Tsuruoka, N., Kodama, S., Tsujimoto, M., Yamamura, Y., Tanaka, T., et al. (1997). Molecular cloning of a novel trypsin-like serine protease (neurosin) preferentially expressed in brain. Biochim. Biophys. Acta1350, 11–14.10.1016/S0167-4781(96)00187-XSearch in Google Scholar

Ye, S. and Goldsmith, E.J. (2001). Serpin and other covalent protease inhibitors. Curr. Opin. Struct. Biol.11, 740–745.10.1016/S0959-440X(01)00275-5Search in Google Scholar

Yoshida, S., Taniguchi, M., Hirata, A., and Shiosaka, S. (1998a). Sequence analysis and expression of human neuropsin cDNA and gene. Gene213, 9–16.10.1016/S0378-1119(98)00232-7Search in Google Scholar

Yoshida, S., Taniguchi, M., Suemoto, T., Oka, T., He, X., and Shiosaka, S. (1998b). cDNA cloning and expression of a novel serine protease, TLSP. Biochim. Biophys. Acta1399, 225–228.10.1016/S0167-4781(98)00116-XSearch in Google Scholar

Yousef, G.M. and Diamandis, E.P. (1999). The new kallikrein-like gene, KLK-L2. Molecular characterization, mapping, tissue expression, and hormonal regulation. J. Biol. Chem.274, 37511–37516.10.1074/jbc.274.53.37511Search in Google Scholar

Yousef, G.M. and Diamandis, E.P. (2000). The expanded human kallikrein gene family: locus characterization and molecular cloning of a new member, KLK-L3 (KLK9). Genomics65, 184–194.10.1006/geno.2000.6159Search in Google Scholar

Yousef, G.M. and Diamandis, E.P. (2001). The new human tissue kallikrein gene family: structure, function, and association to disease. Endocr. Rev.22, 184–204.Search in Google Scholar

Yousef, G.M., Luo, L.Y., Scherer, S.W., Sotiropoulou, G., and Diamandis, E.P. (1999a). Molecular characterization of zyme/protease M/neurosin (PRSS9), a hormonally regulated kallikrein-like serine protease. Genomics62, 251–259.10.1006/geno.1999.6012Search in Google Scholar

Yousef, G.M., Obiezu, C.V., Luo, L.Y., Black, M.H., and Diamandis, E.P. (1999b). Prostase/KLK-L1 is a new member of the human kallikrein gene family, is expressed in prostate and breast tissues, and is hormonally regulated. Cancer Res.59, 4252–4256.Search in Google Scholar

Yousef, G.M., Chang, A., Scorilas, A., and Diamandis, E.P. (2000a). Genomic organization of the human kallikrein gene family on chromosome 19q13.3–q13.4. Biochem. Biophys. Res. Commun.276, 125–133.10.1006/bbrc.2000.3448Search in Google Scholar

Yousef, G.M., Scorilas, A., Magklara, A., Soosaipillai, A., and Diamandis, E.P. (2000b). The KLK7 (PRSS6) gene, encoding for the stratum corneum chymotryptic enzyme is a new member of the human kallikrein gene family – genomic characterization, mapping, tissue expression and hormonal regulation. Gene254, 119–128.10.1016/S0378-1119(00)00280-8Search in Google Scholar

Yousef, G.M., Scorilas, A., and Diamandis, E.P. (2000c). Genomic organization, mapping, tissue expression, and hormonal regulation of trypsin-like serine protease (TLSP PRSS20), a new member of the human kallikrein gene family. Genomics63, 88–96.10.1006/geno.1999.6072Search in Google Scholar PubMed

Yousef, G.M., Magklara, A., and Diamandis, E.P. (2000d). KLK12 is a novel serine protease and a new member of the human kallikrein gene family – differential expression in breast cancer. Genomics69, 331–341.10.1006/geno.2000.6346Search in Google Scholar PubMed

Yousef, G.M., Chang, A., and Diamandis, E.P. (2000e). Identification and characterization of KLK-L4, a new kallikrein-like gene that appears to be down-regulated in breast cancer tissues. J. Biol. Chem.275, 11891–11898.10.1074/jbc.275.16.11891Search in Google Scholar

Yousef, G.M., Scorilas, A., Jung, K., Ashworth, L.K., and Diamandis, E.P. (2001a). Molecular cloning of the human kallikrein 15 gene (KLK15). Up-regulation in prostate cancer. J. Biol. Chem.276, 53–61.10.1074/jbc.M005432200Search in Google Scholar

Yousef, G.M., Magklara, A., Chang, A., Jung, K., Katsaros, D., and Diamandis, E.P. (2001b). Cloning of a new member of the human kallikrein gene family, KLK14, which is down-regulated in different malignancies. Cancer Res.61, 3425–3431.Search in Google Scholar

Yousef, G.M., Kishi, T., and Diamandis, E.P. (2003). Role of kallikrein enzymes in the central nervous system. Clin. Chim. Acta329, 1–8.10.1016/S0009-8981(03)00004-4Search in Google Scholar

Yu, H. and Diamandis, E.P. (1993). Ultrasensitive time-resolved immunofluorometric assay of prostate-specific antigen in serum and preliminary clinical studies. Clin. Chem.39, 2108–2114.10.1093/clinchem/39.10.2108Search in Google Scholar